Home

Schizophrenia

Read time: 5 min

Satellite symposium

Can increased focus on patient perspectives improve outcomes in the treatment of schizophrenia?

Discordance between the treatment goals of patients and their clinicians is important, can lead to...

Professor James MacCabe defines Treatment Resistance Schizophrenia

Depression, Schizophrenia

Read time: 4 min

Congress highlights

Towards new treatment options for MDD and schizophrenia: a role for D2 receptor partial agonists

Major depressive disorder (MDD) and schizophrenia share in common the side effect burden associated...

Depression, Schizophrenia

What are you doing to celebrate World Mental Health Day?

We asked advocacy groups from all around the world why it is important to support World Mental...

Read time: 4 min

Congress highlights

Do we have enough psychiatry training in medical education? A Global Perspective

Psychiatric disorders comprise a global public health priority as standalone conditions and are...

Read time: 3 min

Treatment-resistant schizophrenia – results of a survey on its clinical impact and therapeutic strategies

The results of an online survey completed by 204 US psychiatrists on the clinical impact of...

Bipolar, Schizophrenia

Read time: 4 min

Controversial issues in the management of schizophrenia

Controversial issues in the management of schizophrenia — brain shrinkage, dopamine...

Read time: 4 min

Schizophrenia – from prodrome to psychosis

Psychosis is preceded by a 3–4 year prodromal phase in 75% of patients, but only 25% of...

Read time: 3 min

Treatment-resistant schizophrenia through the lens of observational databases

Longitudinal medical data of patients in healthcare databases may provide a better understanding of...

Depression, Schizophrenia

Read time: 1 min

How can you support carers for people with schizophrenia and psychosis?

More than 25.000 carers have already signed up to The Carer Academy, an interactive online course...

Read time: 3 min

Challenges in diagnosing and managing psychosis

Early identification and timely intervention of first episode psychosis is critical for both short...

Read time: 3 min

Survey reveals intriguing differences between Asian countries in antipsychotic prescribing, symptoms, and adverse event reporting

The Research on Asian Psychotropic Prescription Pattern (REAP) studies provide unique insights into...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country